Langerhans cell histiocytosis: report of a single organ involvement in a child

por Buza, Natalia, Lagarde, D. C., Dash, Srikanta, Haque, Salima
Publicado en J Cell Mol Med (2007)

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)

por Santin, Alessandro D., Bellone, Stefania, Buza, Natalia, Schwartz, Peter E.
Publicado en Gynecol Oncol Rep (2016)

Extraskeletal osteosarcoma located to the gallbladder

por Olgyai, Gábor, Horváth, Viktor, Banga, Péter, Kocsis, József, Buza, Natália, Oláh, Attila
Publicado 2006

Regression of chemotherapy-resistant Polymerase ε (POLE) ultra-mutated and MSH6 hyper-mutated endometrial tumors with nivolumab

por Santin, Alessandro D., Bellone, Stefania, Buza, Natalia, Choi, Jungmin, Schwartz, Peter E., Schlessinger, Joseph, Lifton, Richard P.
Publicado en Clin Cancer Res (2016)

Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma

por Pelligra, Silvia, Buza, Natalia, Hui, Pei, Bellone, Stefania, Zeybek, Burak, Ratner, Elena, Schwartz, Peter E., Scambia, Giovanni, Santin, Alessandro D.
Publicado en Gynecol Oncol Rep (2020)

Metachronous vulvar ectopic breast cancer, a case report and literature review

por Aramin, Hermineh, Koirala, Pratistha, Shah, Abhishek, Adams, Kendall, Buza, Natalia, Desai, Sapna, Fairbairn, Melissa, Goldenberg, David, Gao, Wenli, Chuang, Linus, Vidhun, Ramapriya, Andikyan, Vaagn
Publicado en Gynecol Oncol Rep (2019)

Serum Amyloid A (SAA): a Novel Biomarker for Endometrial Cancer

por Cocco, Emiliano, Bellone, Stefania, El-Sahwi, Karim, Cargnelutti, Marilisa, Buza, Natalia, Tavassoli, Fattaneh A., Schwartz, Peter E., Rutherford, Thomas J., Pecorelli, Sergio, Santin, Alessandro D.
Publicado 2010

Exceptional response to pembrolizumab in a metastatic, chemotherapy/radiation-resistant ovarian cancer patient harboring a PD-L1-genetic rearrangement

por Bellone, Stefania, Buza, Natalia, Choi, Jungmin, Zammataro, Luca, Gay, Laurie, Elvin, Julia, Rimm, David L., Liu, Yuting, Ratner, Elena S., Schwartz, Peter E., Santin, Alessandro D.
Publicado en Clin Cancer Res (2018)

Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody

por Varughese, Joyce, Cocco, Emiliano, Bellone, Stefania, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., Rutherford, Thomas J., Buza, Natalia, Pecorelli, Sergio, Santin, Alessandro D.
Publicado 2011

Novel approach for the detection of intraperitoneal micrometastasis using an ovarian cancer mouse model

por Alvero, Ayesha B., Kim, Dongin, Lima, Eydis, Sumi, Natalia J., Lee, Jung Seok, Cardenas, Carlos, Pitruzzello, Mary, Silasi, Dan-Arin, Buza, Natalia, Fahmy, Tarek, Mor, Gil
Publicado en Sci Rep (2017)

Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade

por Casadevall, David, Li, Xiaotong, Powles, Ryan L., Wali, Vikram B., Buza, Natalia, Pelekanou, Vasiliki, Dhawan, Arjun, Foldi, Julia, Szekely, Borbala, Lopez-Giraldez, Francesc, Hatzis, Christos, Pusztai, Lajos
Publicado en JCO Precis Oncol (2019)

Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis

por Ordulu, Zehra, Chai, Hongyan, Peng, Gang, McDonald, Anna G, De Nictolis, Michele, Garcia-Fernandez, Eugenia, Hardisson, David, Prat, Jaime, Li, Peining, Hui, Pei, Oliva, Esther, Buza, Natalia
Publicado en Mod Pathol (2020)

Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)

por Santin, Alessandro D., Deng, Wei, Frumovitz, Michael, Buza, Natalia, Bellone, Stefania, Huh, Warner, Khleif, Samir, Lankes, Heather A., Ratner, Elena S., O’Cearbhaill, Roisin E., Jazaeri, Amir A., Birrer, Michael
Publicado en Gynecol Oncol (2020)

Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carbopl...

por Roque, Dana M., Buza, Natalia, Glasgow, Michelle, Bellone, Stefania, Bortolomai, Ileana, Gasparrini, Sara, Cocco, Emiliano, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Rutherford, Thomas J., Schwartz, Peter E., Santin, Alessandro D.
Publicado 2013

Tubulin-β-III Overexpression by Uterine Serous Carcinomas is a Marker for Poor Overall Survival after Platinum/Taxane Chemotherapy and Sensitivity to Epothilones

por Roque, Dana M., Bellone, Stefania, English, Diana P., Buza, Natalia, Cocco, Emiliano, Gasparrini, Sara, Bortolomai, Ileana, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Rutherford, Thomas J., Schwartz, Peter E., Santin, Alessandro D.
Publicado 2013

HER2/neu as a potential target for immunotherapy in gynecological carcinosarcomas

por Guzzo, Federica, Bellone, Stefania, Buza, Natalia, Hui, Pei, Carrara, Luisa, Varughese, Joyce, Cocco, Emiliano, Betti, Marta, Todeschini, Paola, Gasparrini, Sara, Schwartz, Peter E., Rutherford, Thomas J., Angioli, Roberto, Pecorelli, Sergio, Santin, Alessandro D.
Publicado 2012

Expression of Tissue factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix: Implications for immunotherapy with hI-con1, a factor VII-IgGF(c )chimeric protein...

por Cocco, Emiliano, Varughese, Joyce, Buza, Natalia, Bellone, Stefania, Glasgow, Michelle, Bellone, Marta, Todeschini, Paola, Carrara, Luisa, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Rutherford, Thomas J, Pecorelli, Sergio, Lockwood, Charles J, Santin, Alessandro D
Publicado 2011

Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer

por Albright, Benjamin B., Black, Jonathan D., Passarelli, Rachel, Gysler, Stefan, Whicker, Margaret, Altwerger, Gary, Menderes, Gulden, Buza, Natalia, Hui, Pei, Santin, Alessandro D., Azodi, Masoud, Silasi, Dan-Arin, Ratner, Elena S., Litkouhi, Babak, Schwartz, Peter E.
Publicado en Gynecol Oncol Rep (2018)

T-DM1, a novel antibody–drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo

por English, Diana P, Bellone, Stefania, Schwab, Carlton L, Bortolomai, Ileana, Bonazzoli, Elena, Cocco, Emiliano, Buza, Natalia, Hui, Pei, Lopez, Salvatore, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Rutherford, Thomas J, Santin, Alessandro D
Publicado en Cancer Med (2014)

Human Epidermal Growth Factor 2 (HER2) in Early Stage Uterine Serous Carcinoma: A Multi-Institutional Cohort Study

por Erickson, Britt K., Najjar, Omar, Damast, Shari, Blakaj, Adriana, Tymon-Rosario, Joan, Shahi, Maryam, Santin, Alessandro, Klein, Molly, Dolan, Michelle, Cimino-Mathews, Ashley, Buza, Natalia, Ferriss, J. Stuart, Stone, Rebecca L., Khalifa, Mahmoud, Fader, Amanda N.
Publicado en Gynecol Oncol (2020)